Cited by 4,291Chronic Myeloid Leukemia TreatmentsGenomic variations and chromosomal abnormalitiesAcute Myeloid Leukemia Research

The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

ROWLEY, JANET D.·1973·Nature

DOI 10.1038/243290a0

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1038/243290a0

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

New Technique for Distinguishing between Human Chromosomes
Sumner, A. T., Evans, H. J., & Buckland, R. A. (1971) · Nature New Biology · doi:10.1038/newbio232031a0 · Cited by 1,166
Technique for Identifying Y Chromosomes in Human Interphase Nuclei
Pearson, P. L., Bobrow, M., & Vosa, C. G. (1970) · Nature · doi:10.1038/226078a0 · Cited by 455
DNA Contents of Chromosome Ph 1 and Chromosome 21 in Human Chronic Granulocytic Leukemia
Rudkin, G. T., Hungerford, D. A., & Nowell̀, P. C. (1964) · Science · doi:10.1126/science.144.3623.1229 · Cited by 199
Clinical Implications of Cytogenetic Variants in Chronic Myelocytic Leukemia (CML)
Whang‐Peng, J., Canellos, G. P., Carbone, P. P., & TJIO, J. H. (1968) · Blood · doi:10.1182/blood.v32.5.755.755 · Cited by 179
Philadelphia-Chromosome-Positive and -Negative Chronic Myelocytic Leukemia
Ezdinli, E. Z., SOKAL, J. E., CROSSWHITE, L., & SANDBERG, A. A. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-2-175 · Cited by 177
Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis
Caspersson, T. O., Gahrton, G., Lindsten, J., & Zech, L. (1970) · Experimental Cell Research · doi:10.1016/0014-4827(70)90362-9 · Cited by 172
Chromosome Studies in Preleukemia
Rowley, J. D., Blaisdell, R. K., Jacobson, L., Mikuta, J. C., Byrne, R., & Shepley, L. A. (1966) · Blood · doi:10.1182/blood.v27.6.782.782 · Cited by 132
Self-citation
Distinguishing between the Chromosomes involved in Down's Syndrome (Trisomy 21) and Chronic Myeloid Leukaemia (Ph1) by Fluorescence
O'Riordan, M. L., Robinson, J. A., BUCKTON, K. E., & Evans, H. J. (1971) · Nature · doi:10.1038/230167a0 · Cited by 129
Identification by fluorescence of the G chromosome lost in human meningomas
Mark, J., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1972.tb01017.x · Cited by 115
IDENTIFICATION OF ISOCHROMOSOME 17 IN MYELOID LEUKÆMIA
Lobb, D., Reeves, B. R., & Lawler, S. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90836-7 · Cited by 48

Flagged first, then by citations

Show all 14 references

1 of the 14 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

Chicago Conference. Standardization in human cytogenetics. The National Foundation—March of Dimes (1966).
Paris Conference. Standardization in human cytogenetics. The National Foundation—March of Dimes (1972).
Rowley, J. D., Potter, D., and Mikuta, J., Stain Tech., 46, 97 (1971).
Rowley, J. D., Ann. Génét. (in the press).
Manolov, G., and Manolova, Y., Hereditas, 69, 300 (1971).

Sorted by citations

Items 301–400 of 1,005

Amplification of Nucleic Acids by Polymerase Chain Reaction (PCR) and Other Methods and their Applications
Bej, A. K., Mahbubani, M. H., & Atlas, R. M. (1991) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239109114071 · Cited by 155
Targeted Cancer Therapeutics
Hait, W. N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3836 · Cited by 153
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
Hadzijusufovic, E., Albrecht-Schgoer, K., Huber, K., Hoermann, G., Grebien, F., Eisenwort, G., Schgoer, W., Herndlhofer, S., Kaun, C., Theurl, M., et al. (2017) · Leukemia · doi:10.1038/leu.2017.245 · Cited by 154
ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA
Canaani, E., Steiner-Salz, D., Aghai, E., Gale, R. P., Berrebi, A., & Januszewicz, E. H. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90997-8 · Cited by 153
p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias
van Rhee, F., Hochhaus, A., Lin, F., Melo, J., Goldman, J. M., & Cross, N. C. P. (1996) · Blood · doi:10.1182/blood.v87.12.5213.bloodjournal87125213 · Cited by 152
Evolution of Genetic Techniques: Past, Present, and Beyond
Durmaz, A., Karaca, E., Demkow, U. A., Törüner, G., Schoumans, J., & Çoğulu, Ö. (2015) · BioMed Research International · doi:10.1155/2015/461524 · Cited by 177
Identification of Heme Oxygenase-1 As a Novel BCR/ABL-Dependent Survival Factor in Chronic Myeloid Leukemia
Mayerhofer, M., Florian, S., Krauth, M., Aichberger, K. J., Bilban, M., Marculescu, R., Printz, D., Fritsch, G., Wagner, O. F., Selzer, E., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1200 · Cited by 153
2 BCR-ABL gene variants
Melo, J. V. (1997) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(97)80003-0 · Cited by 151
Nomenclature for G-bands in rat chromosomes
Levan, G. (2009) · Hereditas · doi:10.1111/j.1601-5223.1974.tb01352.x · Cited by 151
Activation of the c-abl Oncogene by Viral Transduction or Chromosomal Translocation Generates Altered c-abl Proteins with Similar In Vitro Kinase Properties
Davis, R. L., Konopka, J. B., & Witte, O. N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.1.204 · Cited by 151
Chromosomal sublocalization of human c-myb and c-fes cellular onc genes
Harper, M., Franchini, G., Love, J., Simon, M. I., Gallo, R. C., & Wong‐Staal, F. (1983) · Nature · doi:10.1038/304169a0 · Cited by 151
Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia.
Erikson, J., Griffin, C. A., ar-Rushdi, A., Valtieri, M., Hoxie, J. A., Finan, J. B., Emanuel, B. S., Rovera, G., Nowell̀, P. C., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1807 · Cited by 151
Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells
Taverna, S., Amodeo, V., Saieva, L., Russo, A. D., Giallombardo, M., Leo, G. D., & Alessandro, R. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-169 · Cited by 150
Chromosome 14 translocation in african and north american burkitt's lymphoma
Hecht, B. K., Epstein, A. L., Kaplan, H. S., & Hecht, F. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190408 · Cited by 150
SELECTIVE TRANSFORMATION OF B LYMPHOCYTES BY E.B. VIRUS
Pattengale, P. K., Smith, R., & Gerber, P. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)93286-8 · Cited by 148
Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.
Gishizky, M. L., Johnson-White, J., & Witte, O. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3755 · Cited by 148
the Viral and Cellular Forms of the Abelson (Dbl) Oncogene
Rosenberg, N. E., & Witte, O. N. (1988) · Advances in virus research · doi:10.1016/s0065-3527(08)60708-3 · Cited by 148
Explaining why Gleevec is a specific and potent inhibitor of Abl kinase
Lin, Y.-L., Meng, Y., Jiang, W., & Roux, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214330110 · Cited by 146
How does DNA break during chromosomal translocations?
Nambiar, M., & Raghavan, S. C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr223 · Cited by 154
Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance
Bishop, R. (2010) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzq009 · Cited by 157
Non‐random karyotypic evolution in chronic myeloid leukemia
Mitelman, F., Levan, G., Nilsson, P., & Brandt, L. P. A. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910180105 · Cited by 146
Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation.
Cory, S., Vaux, D. L., Strasser, A., Harris, A. W., & Adams, J. M. (1999) · PubMed · Cited by 146
Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data
Baudis, M. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-226 · Cited by 145
KEA3: improved kinase enrichment analysis via data integration
Kuleshov, M. V., Xie, Z., London, A. B., Yang, J., Evangelista, J. E., Lachmann, A., Shu, I., Torre, D., & Ma’ayan, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab359 · Cited by 152
The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML
O'Dwyer, M. E., Mauro, M. J., Kurilik, G., Mori, M., Balleisen, S., Olson, S. B., Magenis, E., Capdeville, R., & Druker, B. J. (2002) · Blood · doi:10.1182/blood-2002-03-0777 · Cited by 145
Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015
Thompson, P. A., Kantarjian, H. M., & Cortes, J. E. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.08.010 · Cited by 150
Human Genome and Diseases:¶Double-strand breaks and translocations in cancer
Elliott, B., & Jasin, M. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8429-3 · Cited by 146
Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management
Jabbour, E. J., & Kantarjian, H. M. (2012) · American Journal of Hematology · doi:10.1002/ajh.23282 · Cited by 144
Alternative Forms of the BCR-ABL Oncogene Have Quantitatively Different Potencies for Stimulation of Immature Lymphoid Cells
McLaughlin, J., Chianese, E., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.5.1866 · Cited by 144
Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation
Wang, Y., Cai, D., Brendel, C. A., Barett, C., Erben, P., Manley, P. W., Hochhaus, A., Neubauer, A., & Burchert, A. (2006) · Blood · doi:10.1182/blood-2006-08-040022 · Cited by 147
Chromosomal translocations: revisited yet again
Rowley, J. D. (2008) · Blood · doi:10.1182/blood-2008-04-097931 · Cited by 148
Self-citation
Associations between morphology, karyotype, and clinical features in myeloid leukemias
Bitter, M. A., Beau, M. M. L., Rowley, J. D., Larson, R. A., Golomb, H. M., & Vardiman, J. W. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80002-3 · Cited by 143
Self-citation
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences
Mani, R. S., & Chinnaiyan, A. M. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2883 · Cited by 153
Involvement of Fas-Mediated Apoptosis in the Inhibitory Effects of Interferon-α in Chronic Myelogenous Leukemia
Selleri, C., Sato, T., Vecchio, L. D., Luciano, L., Barrett, A. J., Rotoli, B., Young, N. S., & Maciejewski, J. P. (1997) · Blood · doi:10.1182/blood.v89.3.957 · Cited by 142
C‐abl and bcr are rearranged in a Ph1‐negative CML patient.
Bartram, C. R., Kleihauer, E., de Klein, A., Grosveld, G. C., Teyssier, J., Heisterkamp, N., & Groffen, J. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03683.x · Cited by 142
Effects of aneuploidy on cell behaviour and function
Li, R., & Zhu, J. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00436-9 · Cited by 147
Translocation (9;11)(p21;q23) in three cases of acute monoblastic leukemia
Hagemeijer, A., Hählen, K., Sizoo, W., & Abels, J. (1982) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(82)90001-2 · Cited by 141
Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization
Bentz, M., Cabot, G., Moos, M., Speicher, M., Ganser, A., Lichter, P., & Döhner, H. (1994) · Blood · doi:10.1182/blood.v83.7.1922.1922 · Cited by 141
Genomic diversity correlates with clinical variation in Ph′-negative chronic myeloid leukaemia
Morris, C. M., Reeve, A. E., Fitzgerald, P. H., Hollings, P. E., Beard, M., & Heaton, D. C. (1986) · Nature · doi:10.1038/320281a0 · Cited by 141
STAT5-Dependent CyclinD1 and Bcl-xL Expression in Bcr-Abl-Transformed Cells
de Groot, R. P., Raaijmakers, J. A. M., Lammers, J. J., & Koenderman, L. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0231 · Cited by 140
Construction and characterization of genomic libraries from specific human chromosomes.
Krumlauf, R. K., Jeanpierre, M., & Young, B. D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.9.2971 · Cited by 140
Chromosomes and causation of human cancer and leukemiaXVI. Banding studies of chronic myelocytic leukemia, including five unusual Ph1translocations
Hayata, I., Sakurai, M., Kakati, S., & Sandberg, A. A. (1975) · Cancer · doi:10.1002/1097-0142(197510)36:4 · Cited by 140
Re-emergence of interferon-α in the treatment of chronic myeloid leukemia
Talpaz, M., Hehlmann, R., Quintás‐Cardama, A., Mercer, J., & Cortes, J. E. (2012) · Leukemia · doi:10.1038/leu.2012.313 · Cited by 145
Genomic mechanisms and measurement of structural and numerical instability in cancer cells
Bayani, J., Selvarajah, S., Maire, G., Vukovic, B., Al-Romaih, K. I., Zieleńska, M., & Squire, J. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.006 · Cited by 144
Nonrandom chromosomal abnormalities in hematologic disorders of man.
Rowley, J. D. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.1.152 · Cited by 139
Self-citation
Existing and Emerging Technologies for Tumor Genomic Profiling
MacConaill, L. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5948 · Cited by 144
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase
Mahon, F., Boquimpani, C. M., Kim, D., Benyamini, N., Clementino, N. C. D., Shuvaev, V. A., Ailawadhi, S., Lipton, J. H., Turkina, A., de Paz, R., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1094 · Cited by 138
Chronic Myeloid Leukemia: A Historical Perspective
Goldman, J. M. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.07.001 · Cited by 137
BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia
Salesse, S., & Verfaillie, C. M. (2002) · Oncogene · doi:10.1038/sj.onc.1206082 · Cited by 147
Bcr–Abl variants: biological and clinical aspects
Advani, A. S., & Pendergast, A. M. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00197-7 · Cited by 143
Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia [see comments]
Wada, C., Shionoya, S., Fujino, Y., Tokuhiro, H., Akahoshi, T., Uchida, T., & Ohtani, H. (1994) · Blood · doi:10.1182/blood.v83.12.3449.3449 · Cited by 137
Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli
Holtz, M. S., Forman, S. J., & Bhatia, R. (2005) · Leukemia · doi:10.1038/sj.leu.2403724 · Cited by 136
Microfluidic single cell arrays to interrogate signalling dynamics of individual, patient-derived hematopoietic stem cells
Faley, S. L., Copland, M., Włodkowic, D., Kölch, W., Seale, K. T., Wikswo, J. P., & Cooper, J. M. (2009) · Lab on a Chip · doi:10.1039/b902083g · Cited by 136
Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of theBCRgene
van der Feltz, M. J. M., Shivji, M. K. K., Allen, P. B., Heisterkamp, N., Groffen, J., & Wiedemann, L. M. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.1.1 · Cited by 136
Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations
Bigner, S. H., Mark, J., Bullard, D. E., Mahaley, M. S., & Bigner, D. D. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90172-x · Cited by 136
Dual effect of oxidative stress on leukemia cancer induction and treatment
Udensi, U. K., & Tchounwou, P. B. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0106-5 · Cited by 135
Src Family Kinases Phosphorylate the Bcr-Abl SH3-SH2 Region and Modulate Bcr-Abl Transforming Activity
Meyn, M. A., Wilson, M. B., Abdi, F. A., Fahey, N., Schiavone, A. P., Wu, J., Hochrein, J. M., Engen, J. R., & Smithgall, T. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605902200 · Cited by 137
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease
Eisterer, W., Jiang, X., Christ, O., Glimm, H., Lee, K. H., Pang, E., Lambie, K., Shaw, G., Holyoake, T. L., Petzer, A. L., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403649 · Cited by 135
Measurement of mutagenesis in mammalian cells.
Waldren, C. A., Jones, C., & Puck, T. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1358 · Cited by 135
Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase
Zhao, Q., Ren, C., Liu, L., Chen, J., Shao, Y., Sun, N., Sun, R., Kong, Y., Ding, X., Zhang, X., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01264 · Cited by 134
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr–Abl signal transduction and oncogenesis
Wilson, M. B., Schreiner, S. J., Choi, H.-J., Kamens, J., & Smithgall, T. E. (2002) · Oncogene · doi:10.1038/sj.onc.1206008 · Cited by 136
The BCR gene and philadelphia chromosome-positive leukemogenesis.
Laurent, E., Talpaz, M., Kantarjian, H. M., & Kurzrock, R. (2001) · PubMed · Cited by 134
Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia
Fletcher, J., Lynch, E., Dalton, V. K., Donnelly, M., Tantravahi, R. V., & Sallan, S. E. (1991) · Blood · doi:10.1182/blood.v77.3.435.435 · Cited by 134
Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy
Bhattacharyya, S., Wu, M., Fang, F., Tourtellotte, W. G., Feghali‐Bostwick, C. A., & Varga, J. (2011) · Matrix Biology · doi:10.1016/j.matbio.2011.03.005 · Cited by 133
Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors
Sisk, J. M., Frieman, M. B., & Machamer, C. E. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001047 · Cited by 133
The BCR gene recombines preferentially with Alu elements in complex BCR- ABL translocations of chronic myeloid leukaemia
Jeffs, A. R. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.767 · Cited by 133
Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia
Kantarjian, H., Talpaz, M., Dhingra, K., Estey, E. H., Keating, M. J., Ku, S., Trujillo, J., Huh, Y. O., Stass, S. A., & Kurzrock, R. (1991) · Blood · doi:10.1182/blood.v78.9.2411.2411 · Cited by 133
Mapping of DNAase I sensitive regions on mitotic chromosomes
Kerem, B., Goitein, R., Diamond, G., Cedar, H., & Marcus, M. (1984) · Cell · doi:10.1016/0092-8674(84)90504-x · Cited by 133
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy
Kim, T., Tyndel, M. S., Kim, H. J., Ahn, J.-S., Choi, S. H., Park, H. J., Kim, Y.-K., Kim, S. Y., Lipton, J. H., Zhang, Z., et al. (2017) · Blood · doi:10.1182/blood-2016-04-708560 · Cited by 133
Development of Acute Lymphoblastic Leukemia and Myeloproliferative Disorder in Transgenic Mice Expressing p210bcr/abl: A Novel Transgenic Model for Human Ph1-Positive Leukemias
Honda, H., Oda, H., Suzuki, T., Takahashi, T., Witte, O. N., Ozawa, K., Ishikawa, T., Yazaki, Y., & Hirai, H. (1998) · Blood · doi:10.1182/blood.v91.6.2067 · Cited by 132
Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism
Sirard, C., Laneuville, P., & Dick, J. E. (1994) · Blood · doi:10.1182/blood.v83.6.1575.1575 · Cited by 133
Assessment of clonality in human tumors: a review.
Wainscoat, J. S., & Fey, M. F. (1990) · PubMed · Cited by 132
The structure of the T cell antigen receptor genes in normal and malignant T cells
Minden, M., & Mak, T. W. (1986) · Blood · doi:10.1182/blood.v68.2.327.327 · Cited by 132
Chromosomal Abnormalities and Their Specificity in Human Neoplasms: An Assessment of Recent Observations by Banding Techniques
Mark, J. (1977) · Advances in cancer research · doi:10.1016/s0065-230x(08)61015-5 · Cited by 132
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics
Tefferi, A., Skoda, R. C., & Vardiman, J. W. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.149 · Cited by 136
Regulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression
Reavie, L. B., Buckley, S. M., Loizou, E., Takeishi, S., Aranda-Orgillés, B., Ndiaye‐Lobry, D., Abdel-Wahab, O. I., Ibrahim, S., Nakayama, K. I., & Aifantis, I. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.025 · Cited by 133
The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Pophali, P. A., & Patnaik, M. M. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000165 · Cited by 136
11 Lineage Heterogeneity in Acute Leukaemia: Acute Mixed-lineage Leukaemia and Lineage Switch
Stass, S. A., & Mirro, J. (1986) · Clinics in Haematology · doi:10.1016/s0308-2261(18)30012-2 · Cited by 130
Abnormalities of chromosome #13 in retinoblastomas from individuals with normal constitutional karyotypes
Balaban, G. B., Gilbert, F., Nichols, W. W., Meadows, A. T., & Shields, J. A. (1982) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(82)90058-9 · Cited by 130
Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
Christiansson, L. H., Söderlund, S., Svensson, E., Mustjoki, S. M., Bengtsson, M., Simonsson, B., Olsson‐Strömberg, U., & Loskog, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055818 · Cited by 129
Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage
Jacquel, A., Herrant, M., Legros, L., Belhacène, N., Luciano, F., Pagès, G., Hofman, P. M., & Auberger, P. (2003) · The FASEB Journal · doi:10.1096/fj.03-0322 · Cited by 133
Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia
Holyoake, T. L., Jiang, X., Drummond, M. W., Eaves, A., & Eaves, C. J. (2002) · Leukemia · doi:10.1038/sj.leu.2402444 · Cited by 129
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi, T., Boswell, H. S., Leibowitz, D. S., & Broxmeyer, H. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.167 · Cited by 129
Chronic myeloid leukemia: reminiscences and dreams
Mughal, T. I., Radich, J. P., Deininger, M. W., Apperley, J. F., Hughes, T. P., Harrison, C. J., Gambacorti-Passerini, C. B., Saglio, G. N., Cortes, J. E., & Daley, G. Q. (2016) · Haematologica · doi:10.3324/haematol.2015.139337 · Cited by 135
CHRONIC MYELOGENOUS LEUKAEMIA
Lee, S. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02216.x · Cited by 128
The 5q- abnormality
Nimer, S. D., & Golde, D. W. (1987) · Blood · doi:10.1182/blood.v70.6.1705.1705 · Cited by 128
Clinical Implications of Tumor-Cell Heterogeneity
Epstein, F. H., & Schnipper, L. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605293142206 · Cited by 128
Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
Sawyers, C. L., Timson, L. K., Kawasaki, E. S., Clark, S., Witte, O. N., & Champlin, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.563 · Cited by 128
Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes.
Poddighe, P. J., Moesker, O., Smeets, D., Awwad, B. H., Ramaekers, F. C. S., & Hopman, A. H. N. (1991) · PubMed · Cited by 128
The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications
Medyouf, H. (2017) · Blood · doi:10.1182/blood-2016-11-696070 · Cited by 133
Tunneling nanotube-mediated intercellular vesicle and protein transfer in the stroma-provided imatinib resistance in chronic myeloid leukemia cells
Kolba, M. D., Dudka, W., Zaręba-Kozioł, M., Kominek, A., Ronchi, P., Turos-Korgul, L., Chrościcki, P., Włodarczyk, J., Schwab, Y., Klejman, A., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2045-8 · Cited by 130
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients
Wu, E. Q., Johnson, S., Beaulieu, N., Arana, M., Bollu, V., Guo, A., Coombs, J., Feng, W., & Cortes, J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903396469 · Cited by 126
Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology
McDermott, U., & Settleman, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9054 · Cited by 131
Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches
Abarrategi, A., Mian, S. A., Passaro, D., Rouault‐Pierre, K., Grey, W., & Bonnet, D. A. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172139 · Cited by 130
Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
Burke, M. R., Smith, A. R., & Zheng, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.872729 · Cited by 129
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
Fransecky, L. R., Mochmann, L. H., & Baldus, C. D. (2015) · Molecular and Cellular Therapies · doi:10.1186/s40591-015-0040-8 · Cited by 125
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Mitchell, R., Hopcroft, L. E. M., Baquero, P., Allan, E. K., Hewit, K. D., James, D. T., Hamilton, G. M., Mukhopadhyay, A., O’Prey, J., Hair, A., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx236 · Cited by 129
Polymorphism and recombination events at theABOlocus: a major challenge for genomic ABO blood grouping strategies
Olsson, M. L., & Chester, M. (2001) · Transfusion Medicine · doi:10.1046/j.1365-3148.2001.00320.x · Cited by 125
Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells
Huang, M., Dorsey, J. F., Epling‐Burnette, P. K., Nimmanapalli, R., Landowski, T. H., Mora, L. B., Niu, G., Sinibaldi, D., Bai, F., Kraker, A. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206028 · Cited by 126
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C
Müller, M. C., Gattermann, N., Lahaye, T., Deininger, M. W., Berndt, A., Früehauf, S., Neubauer, A., Fischer, T. H., HOSSFELD, D. K., Schneller, F., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403157 · Cited by 124

Authors: ROWLEY, J. D.
Affiliations: University of Chicago (US)
Corresponding author: ROWLEY, JANET D.
ORCID: ROWLEY, JANET D.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1973-06
Volume: 243
Issue: 5405
Pages: 290-293
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/243290a0
OpenAlex: W1998593414
Cited by: 4,291
References: 14
Citations by year: 2026: 66 · 2025: 83 · 2024: 86 · 2023: 106 · 2022: 121 · 2021: 128 · 2020: 102 · 2019: 105 · 2018: 124 · 2017: 138 · 2016: 131 · 2015: 155 · 2014: 130 · 2013: 148 · 2012: 139
FWCI: 52.60
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords: chronic myeloid leukemia, Philadelphia chromosome, chromosome 22q deletion, chromosome 9q, translocation, quinacrine fluorescence, G-banding, chromosomal abnormalities, cytogenetics
MeSH terms: Adolescent, Adult, Aged, Bone Marrow Cells, Chromosome Aberrations, Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, Fluorescent Dyes, Humans, Karyotyping, Leukemia, Myeloid, Leukocytes, Methods, Middle Aged, Mitosis, Quinacrine, Staining and Labeling, Chromosome Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks